News Release
To: All Concerned
August 5, 2019
Nissui Pharmaceutical Co., Ltd.

New Service Launched:@BactLAB™, the Colony Counter Global Service
Nissui Pharmaceutical Co., Ltd. (Headquarters: Tokyo, Taito-ku, Representative Director, President andCEO: ONO, Tokuya) is pleased to announce that @BactLAB™, an application that uses Amazon Web
Service (AWS) Cloud and Artificial Intelligence (AI) technologies to enable quick and easy counting ofbacterial colonies, is now available to overseas users of CompactDry™. The launch of this application ispart of the company’s strategy of active investment in areas of new growth, for the purpose of contributing
to the development of overseas markets and quality control processes in relation to food hygiene.
Since August, 2018, a limited number of our overseas customers have been testing and using@BactLAB™, a colony counter application developed exclusively for CompactDry™, an easy-to-use
medium for measuring bacteria count and also our most important product for overseas customers. During
this phase we made several improvements to the application, such as faster counting of colonies, collecting
and utilizing AI learning data, new convenience features and additional functions, all of which are now
included in the released service.

-1NISSUI PHARMACEUTICAL Co., Ltd.

@BactLAB™ official website: https://www.nissui-pharm.co.jp/english/products/global/bactlab/
Application available at:

Google Play / Apple Store / Amazon Appstore / Online Service@BactLAB™ Service Overview
・Auto-count with global cloud access, available on multiple devices (PC / Android / iPhone)・Bacteria counting for CompactDry™, by using the Amazon Web Service (AWS) cloud service andArtificial Intelligence (AI) technology.
・Cloud-storage function of counted data
・Exportable reports (in .csv file or .jpeg file format)
・Chat Bot support on the official website* This service is an application designed exclusively for CompactDry™ customers.
* We recommend a Wi-Fi environment when using the smartphone app.
* Depending on the target image, there may be a counting error of up to 8%.
* A colony count result of “0” does not indicate a negative result.
* The cloud image recognition technology used in this service is an AI Technology for image
recognition system, co-developed by Nissui Pharmaceutical Co., Ltd. and Hitachi Solutions, Ltd.
* Nissui Pharmaceutical takes no responsibility for the analysis results provided by this service.

Screenshot: Example of counting colonies cultured in CompactDry™
-2NISSUI PHARMACEUTICAL Co., Ltd.

CompactDry™ EC (Escherichia coli / Coliforms)

E.coli = Blue / Blue-Purple colonies
Coliforms = Red and/or Blue colonies
Enlarged image of colony count (right side)Blue circle drawing = E.coli
Red circle drawing = Coliforms except E.coli
Purple circle drawing = E.coli and Coliforms
Number around circle = Number of colonies
Notices and List of Trademarks appearing on Service Representations and Specifications
・CompactDry™ and @BactLAB™ are trademarks or registered trademarks of Nissui Pharmaceutical Co., Ltd.
・Google, Google Play, Android and other such marks are trademarks of Google Inc.
・Apple and the Apple logo are trademarks of Apple Inc. registered in the USA and other countries. AppStore, AppleCare and iCloud are service marks of Apple Inc. ™ and ® Apple Inc. All rights reserved.
・Amazon and Amazon Web Service are trademarks or registered trademarks of Amazon.com, Inc. or itsaffiliates.
The use of @BactLAB™ and Global Cloud to manage data enables more comprehensive quality control
at suppliers and manufacturing facilities in the food production industry. In the future, we are planningon creating a system where it becomes possible for the quality control department (QC/QA division) at agroup of companies to monitor the status of every step in the process at each site in real time, from raw
material acceptance, processing, production, manufacturing, and deliveries to quality assurance, thus
expediting the business of food hygiene inspections in overseas markets.

For service-related questions, contact us at
Nissui Pharmaceutical Co., Ltd.
CSV Promotions Office
Email: bactlab-1@nissui-pharm.jp
For questions related to this project, contact us at
Nissui Pharmaceutical Co., Ltd.
Division of Business Support, IR, Department of Business Planning
Tel: 03-5846-5617 Email: ir@nissui-pharm.jp
110-8736 Tokyo, Taito-ku, Ueno 3-24-6, Ueno Frontier Tower 20F
https://www.nissui-pharm.co.jp/Blank below-3NISSUI PHARMACEUTICAL Co., Ltd.